Naronapride

• CAT Number: I008241
• CAS Number: 860174-12-5
• Molecular Formula: C27H41ClN4O5
• Molecular Weight: 537.09
• Purity: ≥95%
• Synonyms: [(3R)-1-azabicyclo[2.2.2]octan-3-yl] 6-[(3S,4R)-4-[(4-amino-5-chloro-2-methoxybenzoyl)amino]-3-methoxypiperidin-1-yl]hexanoate
• InChI: InChI=1S/C27H41ClN4O5/c1-35-23-15-21(29)20(28)14-19(23)27(34)30-22-9-13-31(17-25(22)36-2)10-5-3-4-6-26(33)37-24-16-32-11-7-18(24)8-12-32/h14-15,18,22,24-25H,3-13,16-17,29H2,1-2H3,(H,30,34)/t22-,24+,25+/m1/s1
• InChIKey: VGDDOIZXGFJDRC-VJTSUQJLSA-N
• SMILES: CO[C@H]1CN(CC[C@H]1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CCCCCC(=O)O[C@H]3CN4CCC3CC4

Naronapride（Cat No.:I008241）is a selective 5-HT4 receptor agonist, primarily investigated for its potential therapeutic effects in gastrointestinal disorders. By stimulating the 5-HT4 receptor, naronapride enhances motility in the gastrointestinal tract, making it useful in treating conditions such as irritable bowel syndrome (IBS) and constipation. It works by promoting smooth muscle contraction and improving gut motility, thereby alleviating symptoms associated with these disorders. Naronapride has been studied for its ability to improve gastrointestinal transit times and enhance patient outcomes in clinical settings, offering a targeted approach for treating motility-related disorders.